🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
At present, there are no FDA-approved treatments for chemotherapy-induced n...
Status
Completed
Location
Mansoura University
Start Date
2022-04-12
Trial ID
NCT05351021
HYPOTHESIS: Treatment with pioglitazone is more effective in reducing resis...
Status
Completed
Location
Endocrine Outpatient Clinic of the Hospital de Pediatria del CMN "Siglo XXI"
Start Date
2005-10
Trial ID
NCT01396564
Treatments Being Tested
This is a monocentric, open label, randomized Phase II study in patients wi...
Status
Unknown
Location
Fondazione IRCCS Istituto Nazionale dei Tumori
Start Date
2019-10-15
Trial ID
NCT04001725
Treatments Being Tested
The purpose of this study is to assess the effects of ethinylestradiol 30µg...
Status
Unknown
Location
Clinic of Endocrinology
Start Date
2011-02
Trial ID
NCT01459445
Treatments Being Tested
This phase I/II escalation dose study is assessing the efficacy of the reco...
Status
Active Not Recruiting
Location
Institut de Cancerologie de L'Ouest
Start Date
2020-11-17
Trial ID
NCT04536805
Medical scientists have found that people with diabetes who take the drug M...
Status
Completed
Location
Wake Forest Health Sciences
Start Date
2016-08-03
Trial ID
NCT02986659
The main objective of the present project is to evaluate the relevance of r...
Status
Completed
Location
Antonio Hernández
Start Date
2013-01
Trial ID
NCT02302326
Treatments Being Tested
Metformin, an FDA approved first-line drug for the treatment of type 2 diab...
Status
Completed
Location
Einstein College of Medicine of Yeshiva University
Start Date
2014-10
Trial ID
NCT02432287
This is a 16-week double-blind, placebo-controlled (for colesevelam hydroch...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00570739
Prospective, multicentre, double-blind, placebo-controlled, randomised, pro...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-01
Trial ID
NCT06999343
Treatments Being Tested